Skip to main content
. 2022 Sep 17;14(9):1965. doi: 10.3390/pharmaceutics14091965
Ab Antibodies
ADC Antibody-Targeted Cytotoxic Drug Conjugates
ADCC Antibody-Dependent Cellular Cytotoxicity
ADCP Antibody-Dependent Cellular Phagocytosis
ALL Acute Lymphoblastic Leukemia
AML Acute Myeloid Leukemia
BCR B-cell Receptor
BL Burkitt Lymphoma
BSA Bovine Serum Albumin
CAR Chimeric Antigen Receptor
CDC Complement-Dependent Cytotoxicity
DLBCL Diffuse Large B-cell Lymphoma
EC European Commission
EMA European Medicines Agency
EPR Enhanced Permeability and Retention
ESF European Science Foundation
Fab Antigen-Binding Fragment
FDA Food and Drug Administration
HSA Human Serum Albumin
ICI Immune Checkpoint inhibitor
mAbs Monoclonal Antibodies
MPS Mononuclear Phagocyte System
MRI Magnetic Resonance
NHL Non-Hodgkin Lymphoma
NPs Nanoparticles
PC Protein Corona
PEG Polyethylene Glycol
PET Positron Emission Tomography
PLA Poly(Lactide) Acid
PLC Poly(ε-Caprolactone)
PLGA Poly(Lactide-co-Glycolide) Acid
PMMA Poly(Methyl Methacrylate)
PVA Polyvinyl Alcohol
scFv Single-Chain Fragment Variable
SWCNT Single-Walled Carbon Nanotube
WHO World Health Organization